Trade receivables decreased 30.0%
Trade receivables changed -30.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$10.0M→$7.0M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TNET financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure increased 58.8%
Capital expenditure changed +58.8% from the comparable as-filed period.
$17.0M→$27.0M2 prior comparisons
Operating cash flow increased 11.1%
Operating cash flow changed +11.1% from the comparable as-filed period.
$72.0M→$80.0M2 prior comparisons
Working capital increased 18.5%
Working capital changed +18.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$249.0M→$295.0M4 prior comparisons
Revenue decreased 4.6%
Revenue changed -4.6% from the comparable as-filed period.
$1.2B→$1.2B2 prior comparisons
Operating cash flow / net income increased 21.9%
Operating cash flow / net income changed +21.9% from the comparable as-filed period.
2.12→2.582 prior comparisons
Net income decreased 8.8%
Net income changed -8.8% from the comparable as-filed period.
$34.0M→$31.0M2 prior comparisons
Research & development increased 11.1%
Research & development changed +11.1% from the comparable as-filed period.
$18.0M→$20.0M2 prior comparisons
Shares outstanding decreased 4.6%
Shares outstanding changed -4.6% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
48,030,361→45,810,1408 prior comparisons
Current ratio increased 2.5%
Current ratio changed +2.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.11→1.144 prior comparisons
Capex / revenue moved 92 bp higher
Capex / revenue changed +92 basis points from the comparable as-filed period.
1.38%→2.30%2 prior comparisons
Free-cash-flow proxy decreased 3.6%
Free-cash-flow proxy changed -3.6% from the comparable as-filed period.
$55.0M→$53.0M2 prior comparisons
Working capital / assets moved 142 bp higher
Working capital / assets changed +142 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
7.27%→8.69%4 prior comparisons
Current liabilities decreased 5.0%
Current liabilities changed -5.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2B→$2.1B4 prior comparisons
Current assets decreased 2.7%
Current assets changed -2.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.5B→$2.4B4 prior comparisons
Cash & equivalents increased 2.2%
Cash & equivalents changed +2.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$321.0M→$328.0M4 prior comparisons
SBC / revenue moved 7 bp higher
SBC / revenue changed +7 basis points from the comparable as-filed period.
1.38%→1.45%2 prior comparisons
Operating cash-flow margin moved 96 bp higher
Operating cash-flow margin changed +96 basis points from the comparable as-filed period.
5.84%→6.81%2 prior comparisons
Total assets decreased 0.9%
Total assets changed -0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.4B→$3.4B4 prior comparisons
R&D / revenue moved 24 bp higher
R&D / revenue changed +24 basis points from the comparable as-filed period.
1.46%→1.70%2 prior comparisons
Receivables / revenue moved 22 bp lower
Receivables / revenue changed -22 basis points from the comparable as-filed period.
0.81%→0.60%2 prior comparisons
Free-cash-flow margin moved 5 bp higher
Free-cash-flow margin changed +5 basis points from the comparable as-filed period.
4.46%→4.51%2 prior comparisons
Noncurrent long-term debt increased 0.1%
Noncurrent long-term debt changed +0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$895.0M→$896.0M4 prior comparisons
Stock-based compensation unchangedd 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period.
$17.0M→$17.0M2 prior comparisons
Net income increased 43.2%
Net income changed +43.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$37.0M→$53.0M2 prior comparisons
Operating cash flow increased 17.3%
Operating cash flow changed +17.3% from the comparable as-filed period.
$75.0M→$88.0M3 prior comparisons
Free-cash-flow proxy increased 17.5%
Free-cash-flow proxy changed +17.5% from the comparable as-filed period.
$57.0M→$67.0M3 prior comparisons
Shares outstanding decreased 5.5%
Shares outstanding changed -5.5% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
48,589,933→45,904,7388 prior comparisons
Trade receivables decreased 75.0%
Trade receivables changed -75.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$12.0M→$3.0M4 prior comparisons
Current liabilities decreased 15.9%
Current liabilities changed -15.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.5B→$2.1B4 prior comparisons
Current assets decreased 13.7%
Current assets changed -13.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.8B→$2.4B4 prior comparisons
Revenue decreased 4.8%
Revenue changed -4.8% from the comparable as-filed period.
$1.2B→$1.2B2 prior comparisons
Cash & equivalents decreased 12.0%
Cash & equivalents changed -12.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$407.0M→$358.0M4 prior comparisons
Total assets decreased 9.3%
Total assets changed -9.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$3.7B→$3.3B4 prior comparisons
Operating cash flow / net income decreased 18.1%
Operating cash flow / net income changed -18.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.03→1.662 prior comparisons
Current ratio increased 2.6%
Current ratio changed +2.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.1→1.134 prior comparisons
Working capital / assets moved 133 bp higher
Working capital / assets changed +133 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
6.89%→8.22%4 prior comparisons
Working capital increased 8.3%
Working capital changed +8.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$254.0M→$275.0M4 prior comparisons
Capital expenditure increased 16.7%
Capital expenditure changed +16.7% from the comparable as-filed period.
$18.0M→$21.0M3 prior comparisons
SBC / revenue moved 1 bp lower
SBC / revenue changed -1 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.45%→1.44%2 prior comparisons
Operating cash-flow margin moved 141 bp higher
Operating cash-flow margin changed +141 basis points from the comparable as-filed period.
6.06%→7.47%2 prior comparisons
Capex / revenue moved 33 bp higher
Capex / revenue changed +33 basis points from the comparable as-filed period.
1.45%→1.78%2 prior comparisons
Free-cash-flow margin moved 108 bp higher
Free-cash-flow margin changed +108 basis points from the comparable as-filed period.
4.60%→5.69%2 prior comparisons
Noncurrent long-term debt increased 0.2%
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$894.0M→$896.0M4 prior comparisons
Receivables / revenue moved 71 bp lower
Receivables / revenue changed -71 basis points from the comparable as-filed period.
0.97%→0.25%2 prior comparisons
R&D / revenue moved 7 bp higher
R&D / revenue changed +7 basis points from the comparable as-filed period.
1.37%→1.44%2 prior comparisons
Research & development unchangedd 0.0%
Research & development changed +0.0% from the comparable as-filed period.
$17.0M→$17.0M2 prior comparisons
Stock-based compensation decreased 5.6%
Stock-based compensation changed -5.6% from the comparable as-filed period.
$18.0M→$17.0M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.